Member Info for Sangijuelas1

How many people can be tested using the same device in 30 minutes?

You haven't got a test. You have a lab prototype which needs to be turned into a manufacturing prototype and that will need a lot of money.
According to the RNS it sounds like your Messiah Carl hasn't even perfected the final design.

Here is a blood test for Alzheimers that has already been approved and is in use.

https://www.google.com/amp/s/www.the-scientist.com/news-opinion/first-alzheimers-blood-test-rolled-out-for-clinical-use-in-us-68117/amp

One thing is a lab prototype. Quite another is a scaled up version for mass production.

How much cash is there to contract the manufacturer to do this?

How much cash is there to pay the manufacturer to design a prototype for scale up? And to then build a production line?
And there will need to be manufacturer modifications to the existing design.

Good luck with that, given you are an anonymous poster using a pseudonym.

Thanks for being here Sharebel. If you hadn't been I might have been tempted to have a punt.
But thankfully you were here waving your enormous red flag.

Leave it a bit. You will get in well under 60p

It is not NT to buy. Stop lying

You said exactly the same on Tils Sharebel. If you had bought on every drop of that falling knife you would have nothing left.

And it was all the MMs there as well wasn't it?

, I still would like to know how to book you for some ramping

Starknight claimed on Tils that a compassionate use approval for 1 patient meant that the drug Foralumab had been approved by the FDA and spent a whole afternoon claiming that in a bid to drive up the price whilst his employers were selling.
Seriously if anyone is taken in by this lot you deserve all you get.

Just challenging liars making up stuff about trials starting soon cos the Tils tea lady told them.

Why do you try to twist what I say?
I was invested up until last week. I sold out after the update. At a substantial loss.
I retain about 10% of Sipp in Tils for the time being. As maybe in 5 years time they will have made some progress.

They won't add more patients as they go along. It's not a drug trial. It's allowing a patient to access the drug as a last resort and they may or may not make it available to another patient. That's not the same as running a P2 trial.

The main hold up is being sent back to the lab to get more pre clinical data in mice.
If I had not seen the presentation last week, I would probably still be invested. However, apart from the Sipp holding I have sold up.

Enjoy your delusions. Goodnight

It hasn't. You are both lying. They have been sent back to the lab to get more mouse data and they said MS at least will not start until after they have dosed the expanded access programme patient, which will take at least 6 months..
They are not on schedule despite what their receptionist are telling you. Why would you listen to her and not what the CEO said in the presentation?

What P2 trial is due anytime? I hope you are not lying but I think you are.

Yeah but they are talking in the context of pre clinical work. If they were going to start a P1 trial they would say that rather than say in vivo.
Can't be bothered to argue. I will leave you to it

Not deramping, just trying to keep it honest. People say they are here for the long term and things like Affyxell take time.
The slide PL mentioned says hopefully pre clinical in vivo this year so maybe clinical safety trial in humans some time next year.

You know in vivo means in mice right? Just saying, and AS did say in the long royalties interview that Affyxcell is quite a long way off.